January 9, 2018 / 5:52 PM / 6 months ago

BRIEF-GeNeuro Completes Patient Enrollment In Phase 2A Study Of GNbAC1 In Type 1 Diabetes

Jan 9 (Reuters) - GENEURO SA:

* GENEURO COMPLETES PATIENT ENROLLMENT IN PHASE 2A STUDY OF GNBAC1 IN TYPE 1 DIABETES

* AUSTRALIAN PHASE 2A CLINICAL TRIAL ENROLLED 60 ADULT PATIENTS IN MORE THAN 10 CENTERS

* DATA EXPECTED 3Q2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below